Scrip Deals

Scrip Deals

 

Cancer Biomarker Test Advertising Largely OK, NAD Says
2026-03-27 17:24 UTC by Elizabeth Orr

Marketing for a test to detect certain biomarkers associated with oral cancer can stand after just a few tweaks, the BBB National Programs’ National Advertising Division (NAD) said in a ruling issued

      

 

Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative.